ARTICLE | Clinical News
MGCD265: Additional Phase Ib data
September 28, 2015 7:00 AM UTC
Data from 4 evaluable non-small cell lung cancer (NSCLC) patients with c-MET or AXL gene alterations in the Phase Ib expansion cohort of the open-label, dose-escalation, international Phase I/Ib 265-1...